Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Muscle Nerve ; 24(6): 799-808, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11360264

ABSTRACT

Prosaposin is the precursor of the saposins and has both neurotrophic and myelinotrophic activity in vitro and in vivo. Using an antibody specific for the holoprotein, an immunocytochemical survey demonstrated intense staining of adult rat skeletal, cardiac, and smooth muscle cells. Prosaposin immunoreactivity in muscle appears dependent on innervation, as denervated adult rat skeletal muscles showed decreased immunostaining that returned to normal levels after reinnervation. TX14(A), a peptide derived from the neurotrophic sequence of prosaposin, attenuated the decline in muscle mass loss following nerve injury induced by a constricting ligature. In vitro, both L6 myoblasts and primary chick-embryo myoblasts showed similar prosaposin immunopositivity, mainly in myotubes. TX14(A) induced a threefold increase in L6 myoblast fusion during early stages of differentiation without affecting cell proliferation. The fusion process was decreased in vitro in a dose-dependent fashion by addition of a neutralizing anti-prosaposin antibody. These data suggest that, in addition to neurotrophic and myelinotrophic activities, prosaposin has myotrophic properties.


Subject(s)
Glycoproteins/analysis , Muscle Denervation , Muscle, Skeletal/cytology , Muscle, Skeletal/physiology , Nerve Growth Factors/pharmacology , Sciatic Nerve/physiology , Amino Acid Sequence , Animals , Antibodies/pharmacology , Cell Differentiation/drug effects , Cell Fusion , Cell Line , Chick Embryo , Female , Glycoproteins/chemistry , Immunoglobulin G/pharmacology , Immunohistochemistry , Muscle, Skeletal/drug effects , Muscle, Smooth/cytology , Muscle, Smooth, Vascular/cytology , Myocardium/cytology , Nerve Growth Factors/chemistry , Oligopeptides/chemistry , Oligopeptides/pharmacology , Protein Precursors/analysis , Rats , Rats, Sprague-Dawley , Saposins
2.
Int J Dev Neurosci ; 18(8): 869-85, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11154856

ABSTRACT

Classic studies have established that muscle cells exert trophic actions on neurons of the developing peripheral nervous system through the production of neurotrophins. For this reason neurotrophins are also known as 'target-derived factors'. During differentiation, muscle cells also express some neurotrophin receptors, such as the low-affinity p75 neurotrophin receptor, which binds all neurotrophins, and the high affinity tyrosine kinase receptor TrKA, nerve growth factor (NGF) transducing receptor. The functional roles of these receptors in muscle cells are still unclear and only fragmentary and controversial data are available regarding the responsiveness of muscle cells to NGF. The aim of the present study is to investigate the effects of NGF on cells of myogenic lineage. The rat myogenic cell line L6, primary cultures of adult human myoblasts, and the human rhabdomyosarcoma cell line TE-671 were used in this study. As expected, all the three cell types expressed NGF, p75 and TrKA. NGF was expressed by L6 and primary myoblasts following differentiation, but it was constitutively expressed at high levels in the TE-671 rhabdomyosarcoma cells. In L6 myoblasts, p75 receptor was expressed in myoblasts but not in myotubes early after plating; while some primary human myoblasts expressed it at all the time-points tested. Some fusiform cells of the TE-671 rhabdomyosarcoma cell line also expressed p75. TrKA was constitutively immunodetected in all the three cell lines, suggesting that these cells may respond to NGF. Addition of exogenous NGF increased the fusion rate of both primary and L6 myoblasts, as well as the proliferation of the slowly dividing primary myoblasts. Consistently, blocking the action of endogenously produced NGF with a specific neutralizing antibody decreased the percentage of fusion in both primary and L6 myoblasts. On the contrary, blocking the binding of NGF to p75 did not affect the percentage of fusion. Furthermore, neither exogenous NGF nor NGF- or p75-neutralizing antibodies appeared to affect the rhabdomyosarcoma cells, which have a high proliferation rate and do not fuse. Pharmacological inhibition of TrKA signal transduction with K252a (in the nM range) and tyrphostin AG879 (in the low microM range) resulted in a dramatic dose-dependent decrease in proliferation of all of the myogenic cell lines tested. Interestingly, this was especially evident in the rapidly dividing rhabdomyosarcoma cell line. The TrKA inhibitors also blocked fusion of L6 and primary myoblasts and induced morphological changes characterized by the flattening of the cells and a 'spider-like' rearrangement of the intermediate filaments in all three cell lines with some minor differences. A transfection study showed that p75-overexpressing L6 cells do not fuse and present changes in their morphology similar to the TrKA-inhibitors treated L6 cells. These data support the notion that NGF expression in skeletal muscle is not only associated with a classical target-derived neurotrophic function for peripheral nervous system neurons, but also with an autocrine action which affects the proliferation, fusion into myotubes, and cell morphology of developing myoblasts. The present data also suggest that these effects of NGF are mediated by TrKA receptors and that a sustained presence of NGF is needed for increase fusion into myotubes. Lastly, the dramatic anti-proliferative effect of TrKA inhibitors on myogenic cells, and especially on the TE-671 rhabdomyosarcoma cell line, suggests that pharmacological interference with NGF signal transduction could be effective in the control of these malignancies.


Subject(s)
Muscle Fibers, Skeletal/cytology , Nerve Growth Factor/metabolism , Receptor, trkA/metabolism , Stem Cells/cytology , Animals , Antibodies/pharmacology , Carbazoles/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Division/drug effects , Cell Division/physiology , Dose-Response Relationship, Immunologic , Enzyme Inhibitors/pharmacology , In Vitro Techniques , Indole Alkaloids , Muscle Fibers, Skeletal/chemistry , Muscle Fibers, Skeletal/metabolism , Nerve Growth Factor/analysis , Nerve Growth Factor/immunology , Neutralization Tests , Rats , Receptor, Nerve Growth Factor/analysis , Receptor, Nerve Growth Factor/biosynthesis , Receptor, Nerve Growth Factor/immunology , Receptor, trkA/analysis , Rhabdomyosarcoma , Signal Transduction/drug effects , Signal Transduction/physiology , Stem Cells/chemistry , Stem Cells/metabolism , Tumor Cells, Cultured , Tyrphostins/pharmacology
3.
Histochem J ; 31(9): 589-601, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10579628

ABSTRACT

Neurotrophins are expressed in muscle cells both during development and postnatally. Furthermore, during development muscle cells express high levels of the common p75 neurotrophin receptor, which binds all neurotrophins. Only fragmentary and controversial data are available regarding the responsiveness of muscle cells to neurotrophins and the importance of low-affinity p75 receptor in muscle development. The present study investigates in vitro the immunocytochemical expression of p75 in a rat myogenic cell line (L6) at various time points and in response to different coating substrates as a first step in elucidating the regulation of p75 in muscle. We found that in L6 myoblasts, p75 is expressed only at very early stages of maturation and its levels of expression are regulated by the nature of the coating substrates. p75 expression decreases in cells growing on substrates more suitable for myoblast fusion into myotubes. Time course analysis indicates a reverse correlation between myoblast fusion into myotubes and the levels of p75 expression. Myotubes were always p75 negative. Substrates not suitable for the fusion process induced a prolonged presence of p75 in myoblasts with an increase of their apoptosis. We conclude that expression of p75, at least in this in vitro condition, is regulated by the stages of myoblast differentiation and the nature of the coating substrates. According to the observed time- and substrate-related evidences, future studies should investigate in vivo both the regulation of p75 in the myoblast fusion and the effects and the importance of neurotrophins binding during myoblast differentiation.


Subject(s)
Muscles/metabolism , Receptor, Nerve Growth Factor/metabolism , Animals , Apoptosis , Cell Line , Eyeglasses , Muscles/cytology , Peptides , Polystyrenes , Rats , Silicon
4.
Brain Res ; 823(1-2): 234-40, 1999 Mar 27.
Article in English | MEDLINE | ID: mdl-10095035

ABSTRACT

The effects of sciatic nerve lesions on the expression of serotonin 5-HT3 receptor (5-HT3R) alpha subunit in motoneurons of the spinal cord was investigated by semi-quantitative immunohistochemistry. Following sciatic nerve crush, a significant reduction in density of staining in motoneurons was observed in longitudinal sections of the ventral horn at 3 and 15 days on the lesioned side when compared to the contralateral side (p<0.01). At 30 days after crush, after completion of sciatic nerve regeneration and reinnervation of peripheral targets, intensity of staining had returned to normal. Conversely, after sciatic nerve cut, a lesion that does not allow for target reinnervation, highly significant reductions were observed at 3, 15, 30 and 45 days. These results suggest a role for functional contacts with muscular targets in the maintenance of 5-HT3R expression in spinal motoneurons.


Subject(s)
Motor Neurons/metabolism , Receptors, Serotonin/metabolism , Sciatic Nerve/injuries , Spinal Cord/metabolism , Animals , Denervation , Female , Immunohistochemistry , Lumbosacral Region , Nerve Crush , Nerve Regeneration/physiology , Rats , Rats, Sprague-Dawley , Spinal Cord/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...